# A Study to Evaluate Efficacy and Safety of Four Posaconazole Regimens With Placebo and Terbinafine in the Treatment of Toenail Onychomycosis (Study P05082AM2)(COMPLETED)

> **NCT00491764** · PHASE2 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 218 (actual)

## Conditions studied

- Onychomycosis

## Interventions

- **DRUG:** SCH 56592
- **DRUG:** SCH 56592
- **DRUG:** SCH 56592
- **DRUG:** SCH 56592
- **DRUG:** Terbinafine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00491764
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 218 (ACTUAL)
- **Last updated:** 2017-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00491764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00491764, "A Study to Evaluate Efficacy and Safety of Four Posaconazole Regimens With Placebo and Terbinafine in the Treatment of Toenail Onychomycosis (Study P05082AM2)(COMPLETED)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00491764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*